Globe statue


United Kingdom

The life of a business never remains static. Whether your corporate strategy is to expand by growth or to diversify into new sectors and markets, to exit investments or to divest of non-core activities, to raise funds or to list on the public markets, our experts offer you the right mix of legal and commercial advice. Our international team of more than 700 corporate lawyers in over 65 offices worldwide, of whom over 120 are based in the UK, can assist you in all aspects of corporate law, both domestically and internationally.

We advise on M&A, private equity, equity capital markets, joint ventures and corporate advisory issues.

One of the things that stands out is the quality of their senior associates. We have a good working relationship with the partner and excellent support from their senior associates.
Chambers UK, 2016

Read more Read less

Choose area

    Equity Capital Markets

    As a company wanting to raise new investment, you may be considering different sources of funding, including via equity capital. You will be looking for legal advisers with deep experience and a high level of technical expertise, combined with a detailed understanding of the market and a solution-driven approach. Our Equity Capital Markets Team provides this. We regularly advise companies, investment banks and brokers on IPOs and secondary offerings. We also advise on public company M&A and a wide variety of different quoted company transactions, including those that require preparation of a circular as well as approval from shareholders.

    Read more

    Mergers & Acquisitions

    The successful execution of an M&A transaction, whether sell-side or buy-side, requires lawyers who understand their clients' businesses and markets, including the risks associated with their sector and how they can be mitigated in a pragmatic and cost-effective manner. Our M&A Team is structured according to our clients’ sectors and will work with you and your other advisers to produce innovative structures and solutions that address the risks and challenges faced in your M&A transactions.

    Read more


    Show only
    13 January 2017
    CMS most active M&A firm in Europe according to Bl...
    09 Mar 17
    Spotlight Series: Why Corporate Governance matters...
    Platforms: regulators gotta catch ‘em all (TMC Conference 2016)
    There are countless examples of digital innovation but, as is often the case, regulators are not always able to keep pace with the speed of such developments. Europe’s regulators are now heavily focused on how best to manage online platforms.
    13 December 2016
    CMS, Nabarro and Olswang confirm Practice and Sect...
    07 Mar 17
    Spotlight Series: Why Corporate Governance matters...
    Are disruptors especially vulnerable to disruption? (TMC Conferen...
    Many companies aspire to be, or claim to be, “disruptors” in their sectors. It is a term that has become a byword for innovation, technological know-how and the ability to challenge once seemingly established sectors.
    9 December 2016
    CMS advises consortium on purchase of interest in...
    28 Feb 17
    Spotlight Series: Why Corporate Governance matters...
    AIM companies: proper use of social media and the importance of l...
    This month the AIM team of the London Stock Exchange published guidance on AIM companies’ use of social media to communicate with investors and other stakeholders, and the AIM Disciplinary Committee, which is a committee independent of the London Stock Exchange,.
    CMS advises SSE plc on the £621m sale of a 16.7% s...
    Government consultation on strengthening the voice of employees a...
    Under proposals put forward by the Government in a Green Paper published at the end of last month, a particular non-executive director could be tasked with representing the interests of one or more groups of stakeholders in board level discussions.
    Brexit, deal terms and cross-border European dealf...
    Government Green Paper on Corporate Governance - Remuneration Pro...
    2016 has seen a significant number of papers from pressure groups and investor bodies to try and shape the future direction of quoted company director pay. Last week’s long-awaited Government Corporate Governance Green Paper made what is likely to be the final.
    James Parkes
    CMS is advising the UK’s largest ten-pin bowling o...
    CMA secures first director disqualification for breach of competi...
    On 1 December 2016, the Competition and Markets Authority (CMA) announced that it has secured the disqualification of an individual from acting as a director of any UK company for a period of 5 years. This marks the first time the CMA has exercised its powers.
    7 June 2016
    CMS advises Management Team and incoming Chairman...
    High Court: no privilege without proper explanation
    In Astex Therapeutics Limited (‘Astex’) v AstraZeneca AB (‘AZ’) [2016] EWHC 2759 (Ch), the High Court ordered AZ to provide further evidence in order to substantiate its claim to privilege over various documents withheld from disclosure.
    CMS UK launches Brexit checklists